Analysis and Perspectives

Jun 04, 2021

The market is dominated by Endoscopy fluid management for Hysteroscopy (45%) followed by Laparoscopy and Arthroscopy.

May 21, 2021

The maximum hereditary loss prevalence was observed in the United States in the 7MM in 2020, estimates DelveInsight.

May 17, 2021

A scarce Renal Tubular Acidosis market landscape is led by Advicenne’s ADV 7103 offers ample opportunities.

May 14, 2021

Total diagnosed prevalence to increase at a CAGR of 0.64% in the 7MM during the study period 2018-30.

May 10, 2021

The total ALGS prevalent cases in the 7MM were 17,682 in 2020, estimates DelveInsight, which further is set to rise.

May 07, 2021

Discover how COVID-19 impacted the Benign prostatic hyperplasia market heavily in 2020 and how companies are tackling it.

Apr 23, 2021

The ABSSSI pipeline, as per DelveInsight, appears quite active with several emerging candidates in Phase III and Phase II stages of development.

Apr 09, 2021

Off-label therapies continue to dominate the Cancer Anorexia market, which is expected to change in the next decade.

Apr 05, 2021

Emerging therapies include Ritlecitinib, Ritlecitinib/PF-06650833/ Tofacitinib, Abrocitinib, PF-06826647, Brepocitinib (Pfizer), SHR0302 (Reinstone Biopharma)...

Mar 05, 2021

Of all the diagnosed cancers, approximately 22% of the cases are rare cancers or 1 in 5 people diagnosed with cancer has a rare type.